MK8245

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK8245, covering 2010-09-21 to 2010-09-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety and Efficacy of MK8245 in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK8245-005 AM2) [Phase 2]

See pricing